Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Literature Scan

New and noteworthy research from the medical literature landscape
Ultrasound May Be Useful to Assess Subclinical Synovial Inflammation in Hemophilia
Ruth Jessen Hickman, MD
Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML
Leah Lawrence
All-Oral Mezigdomide Combo Shows Early Efficacy in R/R MM
Leah Lawrence
MPN Linked to Lower Death and Cardiac Arrest, Higher Bleeding in Patients Hospitalized With AMI
Katie Robinson
Eligibility Criteria Can Limit Patient Access
Ruth Jessen Hickman, MD
Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease
Lara C. Pullen, PhD
Heavy Menstrual Bleeding Evaluations Should Consider Variations in Product Absorption
Thomas R. Collins
Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL
Thomas R. Collins
Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study
Katie Robinson
New Strategy Boosts Anti-BCMA CAR T-Cell Activity for Patients with Multiple Myeloma
Anna Azvolinsky, PhD
Valoctocogene Roxaparvovec May Provide Lower Bleeding Rates Than Emicizumab in Severe Hemophilia A
Katie Robinson
Investigational BCMA-Directed CAR T-Cell Therapy for R/R Multiple Myeloma Provides Deep Responses, Low Toxicity
Katie Robinson
Cilta-Cel Bests Standard Care in Early Lenalidomide-Refractory MM
Katie Robinson
Switching to Different FVIII Product Not Associated with Anti-FVIII Inhibitor Development
Anna Azvolinsky, PhD
Second-Line Axi-Cel Delivers OS Benefit for R/R LBCL
Leah Lawrence
Isa-Kd Prolongs PFS to Almost Three Years in Early Relapsed MM Follow-up Study
Katie Robinson
Ruxolitinib Demonstrates Superior Benefits in PV Resistant or Intolerant to Hydroxycarbamide
Linda Kossoff
First-Line Subcutaneous Rituximab May Increase PFS in Low Tumor Burden FL
Katie Robinson
Bleeding Symptoms in Patients With Ehlers-Danlos Syndrome Range From Mild to Life-Threatening
Linda Kossoff
JAK2-Unmutated Erythrocytosis From Gliflozins Appears Benign
Thomas R. Collins

Advertisement

Connect with us:

CURRENT ISSUE
Mid-November 2023

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright ©2023 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement